Literature DB >> 28922451

Low medical morbidity and mortality after acute courses of electroconvulsive therapy in a population-based sample.

D M Blumberger1,2, D P Seitz3,4, N Herrmann2,5, J G Kirkham3, R Ng4, C Reimer6, P Kurdyak1,2,4, A Gruneir4,7, M J Rapoport2,5, Z J Daskalakis1,2, B H Mulsant1,2, S N Vigod2,4,8.   

Abstract

BACKGROUND: To determine event rates for specific medical events and mortality among individuals receiving electroconvulsive therapy (ECT).
METHOD: Population-based cohort study using health administrative data of acute ECT treatments delivered in Ontario, Canada, from 2003 to 2011. We measured the following medical event rates, per 10 000 ECT treatments, up to 7 and 30 days post-treatment: stroke, seizure, acute myocardial infarction, arrhythmia, pneumonia, pulmonary embolus, deep vein thrombosis, gastrointestinal bleeding, falls, hip fracture, and mortality.
RESULTS: A total of 135 831 ECT treatments were delivered to 8810 unique patients. Overall medical event rates were 9.1 and 16.8 per 10 000 ECT treatments respectively. The most common medical events were falls (2.7 and 5.5 per 10 000 ECT treatments) and pneumonia (1.8 and 3.8 per 10 000 ECT treatments). Fewer than six deaths occurred on the day of an ECT treatment. This corresponded to a mortality rate of less than 0.4 per 10 000 treatments. Deaths within 7 and 30 days of an ECT treatment, excluding deaths due to external causes (e.g., accidental and intentional causes of death), were 1.0 and 2.4 per 10 000 ECT treatments respectively.
CONCLUSION: Morbidity and mortality events after ECT treatments were relatively low, supporting ECT as a low-risk medical procedure.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  electroconvulsive therapy; morbidity; mortality

Mesh:

Year:  2017        PMID: 28922451     DOI: 10.1111/acps.12815

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  8 in total

1.  Major Adverse Cardiac Events and Mortality Associated with Electroconvulsive Therapy: A Systematic Review and Meta-analysis.

Authors:  Andreas Duma; Mathias Maleczek; Basil Panjikaran; Harald Herkner; Theodore Karrison; Peter Nagele
Journal:  Anesthesiology       Date:  2019-01       Impact factor: 7.892

2.  Patient-level Characteristics and Inequitable Access to Inpatient Electroconvulsive Therapy for Depression: A Population-based Cross-sectional Study: Caractéristiques au niveau du patient et accès inéquitable à la thérapie électroconvulsive pour patients hospitalisés.

Authors:  Tyler S Kaster; Daniel M Blumberger; Tara Gomes; Rinku Sutradhar; Zafiris J Dasklakis; Duminda N Wijeysundera; Simone N Vigod
Journal:  Can J Psychiatry       Date:  2020-07-02       Impact factor: 4.356

3.  Bilateral Forearm Fractures During Modified Electroconvulsive Therapy in a Male Patient With a History of Hyperparathyroidism and Elevated Pseudocholinesterase Activity.

Authors:  James Luccarelli; Carlos Fernandez-Robles; Sheri M Berg; Michael E Henry
Journal:  J ECT       Date:  2019-09       Impact factor: 3.635

4.  Treatment Capacity and Clinical Outcomes for Patients With Schizophrenia Who Were Treated With Electroconvulsive Therapy: A Retrospective Cohort Study.

Authors:  Joanne E Plahouras; Gerasimos Konstantinou; Tyler S Kaster; Daniel Z Buchman; George Foussias; Zafiris J Daskalakis; Daniel M Blumberger
Journal:  Schizophr Bull       Date:  2021-03-16       Impact factor: 9.306

5.  Duration of Treatment in Electroconvulsive Therapy Among Patients Beginning With Acute Course Right Unilateral Brief Pulse Stimuli.

Authors:  James Luccarelli; Thomas H McCoy; Alec P Shannon; Brent P Forester; Stephen J Seiner; Michael E Henry
Journal:  J ECT       Date:  2021-12-01       Impact factor: 3.692

6.  Clinical Effectiveness of Maintenance Electroconvulsive Therapy in Patients with Schizophrenia: A Retrospective Cohort Study.

Authors:  Moshe Isserles; Jesse Remington; Tyler S Kaster; Zafiris J Daskalakis; Daniel M Blumberger
Journal:  J ECT       Date:  2020-03       Impact factor: 3.692

7.  Magnetic Seizure Therapy Compared to Electroconvulsive Therapy for Schizophrenia: A Randomized Controlled Trial.

Authors:  Jiangling Jiang; Jin Li; Yuanhong Xu; Bin Zhang; Jianhua Sheng; Dengtang Liu; Wenzheng Wang; Fuzhong Yang; Xiaoyun Guo; Qingwei Li; Tianhong Zhang; Yingying Tang; Yuping Jia; Zafiris J Daskalakis; Jijun Wang; Chunbo Li
Journal:  Front Psychiatry       Date:  2021-11-25       Impact factor: 4.157

8.  Electroconvulsive therapy protocol adaptation during the COVID-19 pandemic.

Authors:  Joaquín Gil-Badenes; Ricard Valero; Marc Valentí; Elisabet Macau; Maria Jesús Bertran; Gerard Claver; Miquel Bioque; Inmaculada Baeza; Anna Bastidas Salvadó; María Lombraña Mencia; Isabella Pacchiarotti; Miquel Bernardo; Eduard Vieta
Journal:  J Affect Disord       Date:  2020-07-15       Impact factor: 4.839

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.